Intervention effects of BJJP on the proliferation, apoptosis, and EMT of PANC-1 pancreatic cancer cells

doi:10.3969/j.issn.1000-1565.2025.01.008

Abstract

Abstract: To investigate the effects of BJJP on the proliferation, apoptosis, and EMT of PANC-1 pancreatic cancer cells.CCK-8, Colony formation, Western blot, TUNEL scratch, Transwell and immunofluorescence assays were used to detect the effect of BJJP-containing serum on the activity of human normal pancreatic ductal epithelial cells HPNE, and detect the effects of BJJP-containing serum on the proliferation, apoptosis, migration, invasion, EMT, and the protein expression of PI3K/AKT pathway of pancreatic cancer cells PANC-1. The results showed that BJJP-containing serum has no significant effect on the activity of HPNE cells but inhibits the proliferation, migration, invasion, EMT- DOI:10.3969/j.issn.1000-1565.2025.01.008鳖甲煎丸对胰腺癌细胞PANC-1增殖、凋亡和EMT的干预作用熊亚南¹,李以恒¹,张荣花¹,章广玲²,刘志勇²(1.华北理工大学基础医学院, 河北省慢性疾病重点实验室, 河北唐山 063210;2.华北理工大学附属医院,河北省医工融合精准医疗重点实验室, 河北唐山 063000)摘要:为探讨鳖甲煎丸(biejiajian pill,BJJP)对胰腺癌细胞增殖、凋亡和上皮-间充质转化(EMT)的干预作用.采用CCK-8、集落形成、Western blot、TUNEL划痕、Transwell和免疫荧光等实验方法检测BJJP含药血清对人正常胰腺导管上皮细胞HPNE活力的影响,对胰腺癌细胞PANC-1增殖、凋亡、迁移、侵袭、EMT以及PI3K/AKT通路蛋白表达的影响.结果显示:BJJP含药血清对HPNE细胞的活力无明显影响,具有抑制PANC-1细胞的增殖、迁移、侵袭、EMT进程的能力,促进了PANC-1细胞凋亡,抑制了PI3K/AKT通路,综上,鳖甲煎丸能抑制胰腺癌PANC-1细胞的恶性生物学行为,其机制可能与调节PI3K/AKT通路有关.关键词:鳖甲煎丸;胰腺癌;增殖;凋亡;上皮-间充质转化中图分类号:R735.9 文献标志码:A 文章编号:1000-1565(2025)01-0070-12Intervention effects of BJJP on the proliferation, apoptosis, and EMT of PANC-1 pancreatic cancer cellsXIONG Yanan¹,LI Yiheng¹,ZHANG Ronghua¹,ZHANG Guangling²,LIU Zhiyong²(1. Hebei Key Laboratory for Chronic Diseases, School of Basic Medicine, North China University of Science and Technology, Tangshan 063210, China; 2. Hebei Provincial Key Laboratory of Medical-Industrial Integration Precision Medicine, North China University of Science and Technology Affiliated Hospital, Tangshan 063000, China)Abstract: To investigate the effects of BJJP on the proliferation, apoptosis, and EMT of PANC-1 pancreatic cancer cells.CCK-8, Colony formation, Western blot, TUNEL scratch, Transwell and immunofluorescence assays were used to detect the effect of BJJP-containing serum on the activity of human normal pancreatic ductal epithelial cells HPNE, and detect the effects of BJJP-containing serum on the proliferation, apoptosis, migration, invasion, EMT, and the protein expression of PI3K/AKT pathway of pancreatic cancer cells PANC-1. The results showed that BJJP-containing serum has no significant effect on the activity of HPNE cells but inhibits the proliferation, migration, invasion, EMT- 收稿日期:2024-06-12;修回日期:2024-09-14 基金项目:河北省自然科学基金资助项目(H2023209047;H202409077);河北省教育厅在读研究生创新能力培养项目(CXZZSS2024056) 第一作者:熊亚南(1978—),女,华北理工大学副教授,主要从事胰腺癌分子机制研究.E-mail:xiongyanan@ncst.edu.cn 通信作者:刘志勇(1971—),男,华北理工大学教授,博士,主要从事胰腺癌分子机制研究.E-mail:macromicro@126.com 第1期熊亚南等:鳖甲煎丸对胰腺癌细胞PANC-1增殖、凋亡和EMT的干预作用河北大学学报(自然科学版) 第45卷process and PI3K/AKT pathway, enhances the apoptosis of pancreatic cancer PANC-1 cells.Studies have shown that BJJP inhibits the malignant biological behavior of pancreatic cancer PANC-1 cells, and the mechanism may be related to the regulation of PI3K/AKT pathway.

Key words: BJJP, pancreatic cancer, proliferation, apoptosis, EMT

CLC Number:

R735.9

XIONG Yanan,LI Yiheng,ZHANG Ronghua,ZHANG Guangling,LIU Zhiyong. Intervention effects of BJJP on the proliferation, apoptosis, and EMT of PANC-1 pancreatic cancer cells[J]. Journal of Hebei University(Natural Science Edition), 2025, 45(1): 70-81.

References

[1] SIEGEL R L, MILLER K D, FUCHS H E, et al.Cancer statistics, 2021[J].CA Cancer J Clin, 2021, 71(1):7-33. DOI: 10.3322/caac.21654.
[2] WENG Y C, QIAN H, HONG L W, et al. Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer[J]. Front Immunol, 2023, 13: 1089008. DOI: 10.3389/fimmu.2022.1089008.
[3] WANG S M, LONG S Q, DENG Z Y, et al. Positive role of Chinese herbal medicine in cancer immune regulation[J]. Am J Chin Med, 2020, 48(7): 1577-1592. DOI: 10.1142/S0192415X20500780.
[4] WANG C Y, BAI X Y, WANG C H. Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development[J]. Am J Chin Med, 2014, 42(3): 543-559. DOI: 10.1142/S0192415X14500359.
[5] 李杳瑶, 刘华, 孙铜林, 等.鳖甲煎丸经AT1R/VEGF信号通路对肝癌血管生成的影响[J].解剖学研究, 2023, 45(6): 523-528. DOI: 10.20021/j.cnki.1671-0770.2023.06.04.
[6] KLEIN A P. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(7): 493-502. DOI: 10.1038/s41575-021-00457-x.
[7] ZHANG Z, AUYEUNG K K W, SZE S C W, et al. The dual roles of calycosin in growth inhibition and metastatic progression during pancreatic cancer development: a “TGF-β paradox”[J]. Phytomedicine, 2020, 68: 153177. DOI: 10.1016/j.phymed.2020.153177.
[8] 杨利, 林洪升, 李屏, 等.可变剪切事件在鳖甲煎丸抑制肝癌细胞增殖过程中的作用机制及变化[J].重庆医学, 2023, 52(14): 2101-2106. DOI: 10.3969/j.issn.1671-8348.2023.14.004.
[9] MORANA O, WOOD W, GREGORY C D. The apoptosis paradox in cancer[J]. Int J Mol Sci, 2022, 23(3): 1328. DOI: 10.3390/ijms23031328.
[10] LOPEZ A, REYNA D E, GITEGO N, et al. Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer[J]. Nat Commun, 2022, 13(1): 1199. DOI: 10.1038/s41467-022-28741-7.
[11] SAHIB A S, FAWZI A, ZABIBAH R S, et al. miRNA/epithelial-mesenchymal axis(EMT)axis as a key player in cancer progression and metastasis: a focus on gastric and bladder cancers[J]. Cell Signal, 2023, 112: 110881. DOI: 10.1016/j.cellsig.2023.110881.
[12] JOSHI V B, GUTIERREZ RUIZ O L, RAZIDLO G L. The cell biology of metastatic invasion in pancreatic cancer: updates and mechanistic insights[J]. Cancers, 2023, 15(7): 2169. DOI: 10.3390/cancers15072169.
[13] CHEN W C, YANG X M, SUN J L, et al. Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRβ signaling in cancer-associated fibroblasts[J]. J Ethnopharmacol, 2023, 301: 115825. DOI: 10.1016/j.jep.2022.115825.
[14] MEHRA S, DESHPANDE N, NAGATHIHALLI N. Targeting PI3K pathway in pancreatic ductal adenocarcinoma: rationale and progress[J]. Cancers, 2021, 13(17): 4434. DOI: 10.3390/cancers13174434.
[15] YU L, WEI J, LIU P D. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer[J]. Semin Cancer Biol, 2022, 85: 69-94. DOI: 10.1016/j.semcancer.2021.06.019.
[16] TIAN Y, CHEN Z H, WU P, et al. MIR497HG-derived miR-195 and miR-497 mediate tamoxifen resistance via PI3K/AKT signaling in breast cancer[J]. Adv Sci, 2023, 10(12): e2204819. DOI: 10.1002/advs.202204819.
[17] SONG M Q, BODE A M, DONG Z G, et al. AKT as a therapeutic target for cancer[J]. Cancer Res, 2019, 79(6): 1019-1031. DOI: 10.1158/0008-5472.CAN-18-2738.
[18] POPOVA N V, JÜCKER M. The role of mTOR signaling as a therapeutic target in cancer[J]. Int J Mol Sci, 2021, 22(4): 1743. DOI: 10.3390/ijms22041743. (